HEAD & NECK CANCER
Clinical trials for HEAD & NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD & NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radioactive drug targets hard-to-treat cancers in early trial
Disease control Not yet recruitingThis early-phase trial tests a new radioactive drug (177Lu-INN805) in 10 adults with advanced solid tumors like head & neck, thyroid, lung, breast, or sarcoma cancer who have not responded to standard treatments. The drug is given every 6 weeks for up to 4 cycles to find the safe…
Matched conditions: HEAD & NECK CANCER
Phase: EARLY_PHASE1 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Could a simple pill before surgery beat head and neck cancer?
Disease control Not yet recruitingThis study tests giving a short course of capecitabine pills before surgery for people with newly diagnosed, advanced head and neck cancer that is not linked to HPV. The goal is to shrink tumors early, make surgery easier, and improve long-term outcomes. About 75 participants wil…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New drug combo aims to shrink throat tumors before surgery
Disease control Not yet recruitingThis study tests two experimental drugs, vibecortamab and putilimab, given before surgery for people with locally advanced laryngeal cancer. The goal is to see if the combination can shrink tumors enough to improve surgical outcomes and preserve voice function. Ten participants w…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New cell therapy aims to shrink Hard-to-Treat cancers
Disease control Not yet recruitingThis study tests a new cell therapy called SL-28 for people with advanced solid tumors that have not responded to standard treatments. The therapy uses donor immune cells to attack the cancer. The goal is to see if it is safe and can shrink tumors in up to 60 participants with va…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Protein shake may shield cancer patients from brutal radiation mouth sores
Symptom relief Not yet recruitingThis study tests if a daily whey protein drink can lower the chance of severe mouth sores caused by radiation therapy in people with head and neck cancer. About 504 adults will receive either the protein supplement or a placebo during their radiation treatment. The goal is to see…
Matched conditions: HEAD & NECK CANCER
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Symptom relief
Last updated May 26, 2026 03:06 UTC